Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6536
    +0.0013 (+0.20%)
     
  • OIL

    83.64
    +0.07 (+0.08%)
     
  • GOLD

    2,348.80
    +6.30 (+0.27%)
     
  • Bitcoin AUD

    97,857.24
    -1,424.48 (-1.43%)
     
  • CMC Crypto 200

    1,383.71
    -12.82 (-0.95%)
     
  • AUD/EUR

    0.6105
    +0.0032 (+0.52%)
     
  • AUD/NZD

    1.0997
    +0.0039 (+0.36%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Company News for Feb 27, 2020

  • Shares of Novavax, Inc. NVAX surged 16% after the late-stage biotechnology company highlighted progress in efforts to develop novel vaccine to shield against coronavirus.

  • Shares of B&G Foods, Inc. BGS gained 23.2% after the company reported adjusted earnings of 28 cents per share, which were in line with the Zacks Consensus Estimate.

  • Shares of Sabre Corporation SABR declined 16.1% after the company reported quarterly earnings of $0.16 per share, which missed the Zacks Consensus Estimate of $0.17.

  • Shares of Chesapeake Energy Corporation CHK declined 30.5% after the company reported revenues of $969 million, which missed the Zacks Consensus Estimate of $1,212 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chesapeake Energy Corporation (CHK) : Free Stock Analysis Report
 
Novavax, Inc. (NVAX) : Free Stock Analysis Report
 
B&G Foods, Inc. (BGS) : Free Stock Analysis Report
 
Sabre Corporation (SABR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research